Electronic pillboxes (MEMS) to assess the relationship between medication adherence and blood pressure control in primary care

Scandinavian Journal of Primary Health Care

Volumn 25, Issue 4, 2007, Pages 202-207

  Zeller, Andreas ^a,b   Schroeder, Knut ^a   Peters, Tim J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adherence; Blood pressure control; Compliance; Family practice; Hypertension; Primary care

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; FEMALE; GENERAL PRACTICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONITORING; PATIENT COMPLIANCE; PILL; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; UNITED KINGDOM;

AGED; ANTIHYPERTENSIVE AGENTS; DRUG MONITORING; DRUG PACKAGING; FAMILY PRACTICE; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICATION SYSTEMS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES;

EID: 36549029831     PISSN: 02813432     EISSN: 15027724     Source Type: Journal    
DOI: 10.1080/02813430701651954     Document Type: Article

References (32)

1. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
2. Wolf-Maier K, Cooper RS, Kramer H, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43:10-7.
3. Rudd P. Clinicians and patients with hypertension: Unsettled issues about compliance. Am Heart J 1995;30:572-9.
4. Briggs WA, Lowenthal DT, Cirksena WJ, Price WE, Gibson TP, Flamenbaum W. Propranolol in hypertensive dialysis patients: Efficacy and compliance. Clin Pharmacol Ther 1975;18:606-12.
5. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
6. Podell RN, Kent D, Keller K. Patient psychological defenses and physician response in the long-term treatment of hypertension. J Fam Pract 1976;3:145-9.
7. Schroeder K, Fahey T, Hollinghurst S, Peters TJ. Nurse-led adherence support in hypertension: A randomized controlled trial. Fam Pract 2005;22:144-51.
8. Wetzels GE, Nelemans P, Schouten JS, Prins MH. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: A systematic review. J Hypertens 2004;22:1849-55.
9. Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Relationship between medication adherence and blood pressure in primary care: Prospective study. J Hum Hypertens 2006;20:625-7.
10. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21:1011-53.
11. Williams B, Poulter NR, Brown MJ, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004;328:634-40.
12. Sabeté E, et al. Adherence to long-term therapy: Evidence for action. Geneva, Switzerland: World Health Organization; 2003.
13. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-63.
14. Hosie J, Wiklund I. Managing hypertension in general practice: Can we do better? J Hum Hypertens 1995;9:S15-8.
15. Steinman MA, Fischer MA, Shlipak MG, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004;117:747-54.
16. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med 2001;135:825-34.
17. Cranney M, Warren E, Barton S, Gardner K, Walley T. Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract 2001;18:359-63.
18. Hedblad B, Nerbrand C, Ekesbo R, et al. High blood pressure despite treatment: Results from a cross-sectional primary healthcare-based study in southern Sweden. Scand J Prim Health Care 2006;24:224-30.
19. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: Factors associated with lack of blood pressure control in the community. Hypertension 2000;36:594-9.
20. Bertholet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in the management of hypertension. J Clin Hypertens (Greenwich) 2000;2:258-62.
21. Burnier M, Schneider MP, Chiolero A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: The basis for rational therapeutic decisions. J Hypertens 2001;19:335-41.
22. Nuesch R, Schroeder K, Dieterle T, Martina B, Battegay E. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: A prospective case-control study. BMJ 2001;323:142-6.
23. Mallion JM, Dutrey-Dupagne C, Vaur L, et al. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996;14:137-44.
24. Vaur L, Vaisse B, Genes N, Elkik F, Legrand C, Poggi L. Use of electronic pill boxes to assess risk of poor treatment compliance: Results of a large-scale trial. Am J Hypertens 1999;12:374-80.
25. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296-310.
26. Leenen FH, Wilson TW, Bolli P, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: A randomized clinical trial using electronic monitoring. Can J Cardiol 1997;13:914-20.
27. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002;CD000011.
28. Wickstrom G, Bendix T. The "Hawthorne effect" - What did the original Hawthorne studies actually show? Scand J Work Environ Health 2000;26:363-7.
29. McKenney JM, Munroe WP, Wright JT, Jr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol 1992;32:277-83.
30. Mengden T, Binswanger B, Spuhler T, Weisser B, Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 1993;11:1403-11.
31. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10.
32. Primatesta P, Poulter NR. Improvement in hypertension management in England: Results from the Health Survey for England 2006. J Hypertens 2003;24:1193-200.